MWNA
PRVL

Marshall Wace North America’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Marshall Wace North America’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,414
Closed -$520K – 1656
2019
Q2 		$520K Buy
+39,414
New +$520K ﹤0.01% 882